Advanced in Primitive Neuroectodermal Tumor (PNET)

Dr. Douglas F. Ciuba

Radiation Oncology
Radiation Oncology Of Columbus PC
1831 5th Ave, 
Columbus, GA 
Accepting New Patients
Offers Telehealth
Advanced in Primitive Neuroectodermal Tumor (PNET)
Radiation Oncology Of Columbus PC
1831 5th Ave, 
Columbus, GA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Douglas Ciuba is a Radiation Oncologist in Columbus, Georgia. Dr. Ciuba is rated as an Advanced provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). His top areas of expertise are Adenoid Cystic Carcinoma, Lung Cancer, Pleuropulmonary Blastoma, and Familial Prostate Cancer. Dr. Ciuba is currently accepting new patients.

His clinical research consists of co-authoring 1 peer reviewed article and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Radiation Oncology
Licenses
Radiology in GA
Hospital Affiliations
St Francis Hospital- Emory Healthcare
Piedmont Columbus Regional Midtown
Piedmont Columbus Regional Northside
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Alliant Health
  • HMO
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareSource
  • HMO
Cigna
  • EPO
  • HMO
  • PPO
Friday Health

Accepted plan types not found. Please verify directly with the provider.

Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 8 Less Insurance Carriers -

Locations

RADIATION ONCOLOGY OF COLUMBUS PC
1831 5th Ave, Columbus, GA 31904

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

Androgen Deprivation Therapy and High Dose Radiotherapy With or Without Whole-Pelvic Radiotherapy in Unfavorable Intermediate or Favorable High Risk Prostate Cancer: A Phase III Randomized Trial
Androgen Deprivation Therapy and High Dose Radiotherapy With or Without Whole-Pelvic Radiotherapy in Unfavorable Intermediate or Favorable High Risk Prostate Cancer: A Phase III Randomized Trial
Enrollment Status: Active_not_recruiting
Publish Date: September 30, 2025
Intervention Type: Radiation
Study Phase: Phase 3
GRECO-1: Phase I/II, Randomized, Placebo-Controlled Study of Stereotactic Body Radiation Therapy (SBRT) and GC4711 for Centrally Located or Large, Node-Negative Non-Small Cell Lung Cancer (NSCLC)
GRECO-1: Phase I/II, Randomized, Placebo-Controlled Study of Stereotactic Body Radiation Therapy (SBRT) and GC4711 for Centrally Located or Large, Node-Negative Non-Small Cell Lung Cancer (NSCLC)
Enrollment Status: Terminated
Publish Date: April 30, 2024
Intervention Type: Drug
Study Drug: GC4711
Study Phase: Phase 1/Phase 2
ROMAN: Reduction in Oral Mucositis With Avasopasem Manganese (GC4419) - Phase 3 Trial in Patients Receiving Chemoradiotherapy for Locally-Advanced, Non-Metastatic Head and Neck Cancer
ROMAN: Reduction in Oral Mucositis With Avasopasem Manganese (GC4419) - Phase 3 Trial in Patients Receiving Chemoradiotherapy for Locally-Advanced, Non-Metastatic Head and Neck Cancer
Enrollment Status: Completed
Publish Date: October 24, 2023
Intervention Type: Drug
Study Drug: GC4419
Study Phase: Phase 3
A Phase 2b/3, Multicenter, Randomized, Double-blind, Placebo-controlled Study Comparing the Efficacy and Safety of Clonidine Mucoadhesive Buccal Tablet to Placebo to Prevent Chemoradiotherapy-induced Severe Oral Mucositis in Patients With Oropharyngeal Cancer
A Phase 2b/3, Multicenter, Randomized, Double-blind, Placebo-controlled Study Comparing the Efficacy and Safety of Clonidine Mucoadhesive Buccal Tablet to Placebo to Prevent Chemoradiotherapy-induced Severe Oral Mucositis in Patients With Oropharyngeal Cancer
Enrollment Status: Terminated
Publish Date: May 31, 2023
Intervention Type: Drug
Study Drug: Clonidine HCl Mucoadhesive Buccal Tablet
Study Phase: Phase 2/Phase 3
A Phase 2a Open-Label Trial of the Effects of Intravenous GC4419 on the Incidence and Severity of Esophagitis in Subjects Receiving Chemoradiotherapy for Lung Cancer
A Phase 2a Open-Label Trial of the Effects of Intravenous GC4419 on the Incidence and Severity of Esophagitis in Subjects Receiving Chemoradiotherapy for Lung Cancer
Enrollment Status: Terminated
Publish Date: March 23, 2023
Intervention Type: Drug
Study Drug: GC4419
Study Phase: Phase 2
Open-label, Randomized, Controlled, Phase 3 Safety and Efficacy Study of Trans Sodium Crocetinate With Radiation Therapy and Temozolomide in Newly Diagnosed Glioblastoma (GBM) Biopsy-Only Subjects
Open-label, Randomized, Controlled, Phase 3 Safety and Efficacy Study of Trans Sodium Crocetinate With Radiation Therapy and Temozolomide in Newly Diagnosed Glioblastoma (GBM) Biopsy-Only Subjects
Enrollment Status: Terminated
Publish Date: July 22, 2021
Intervention Type: Drug, Other
Study Phase: Phase 3
View 5 Less Clinical Trials

1 Total Publications

Updated feasibility and reproducibility results of multi-institutional study of noninvasive breast tumor bed boost.
Updated feasibility and reproducibility results of multi-institutional study of noninvasive breast tumor bed boost.
Journal: Brachytherapy
Published: April 16, 2016
Similar Doctors
Experienced in Primitive Neuroectodermal Tumor (PNET)
Dr. Woodrow W. Mcwilliams
Radiation Oncology
Experienced in Primitive Neuroectodermal Tumor (PNET)
Dr. Woodrow W. Mcwilliams
Radiation Oncology

Radiation Oncology Of Columbus PC

1831 5th Ave, 
Columbus, GA 
 (0.1 miles away)
706-571-1050
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Woodrow Mcwilliams is a Radiation Oncologist in Columbus, Georgia. Dr. Mcwilliams is rated as a Distinguished provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). His top areas of expertise are Familial Prostate Cancer, Prostate Cancer, Laryngeal Cancer, and Pleuropulmonary Blastoma. Dr. Mcwilliams is currently accepting new patients.

Experienced in Primitive Neuroectodermal Tumor (PNET)
Dr. Diana A. Santiago
Radiation Oncology
Experienced in Primitive Neuroectodermal Tumor (PNET)
Dr. Diana A. Santiago
Radiation Oncology

Therapeutic Radiation Oncology, PC

745 Poplar Rd, 
Newnan, GA 
 (62.0 miles away)
770-254-9600
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Diana Santiago is a Radiation Oncologist in Newnan, Georgia. Dr. Santiago is rated as an Advanced provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). Her top areas of expertise are Laryngeal Cancer, Pleuropulmonary Blastoma, Lung Cancer, and Familial Prostate Cancer. Dr. Santiago is currently accepting new patients.

Experienced in Primitive Neuroectodermal Tumor (PNET)
Dr. John F. Cabelka
Radiation Oncology
Experienced in Primitive Neuroectodermal Tumor (PNET)
Dr. John F. Cabelka
Radiation Oncology

The East Alabama Health Care Authority

2000 Pepperell Pkwy, 
Opelika, AL 
 (26.6 miles away)
334-749-3411
Languages Spoken:
English
See accepted insurances
Accepting New Patients

John Cabelka is a Radiation Oncologist in Opelika, Alabama. Dr. Cabelka is rated as an Advanced provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). His top areas of expertise are Familial Prostate Cancer, Prostate Cancer, Pleuropulmonary Blastoma, and Breast Cancer. Dr. Cabelka is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Ciuba's expertise for a condition
ConditionClose
    View All 14 Advanced Conditions
    View All 70 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile